Celltrion
Clinical trials sponsored by Celltrion, explained in plain language.
-
New psoriasis treatment goes Head-to-Head with established drug
Disease control OngoingThis study aims to see if a new psoriasis medication called CT-P55 works as well and is as safe as an already approved drug called Cosentyx. It involves 153 adults with moderate to severe plaque psoriasis. Participants are randomly assigned to receive either the new treatment or …
Phase: PHASE3 • Sponsor: Celltrion • Aim: Disease control
Last updated Apr 02, 2026 03:41 UTC
-
New hope for stubborn blood sugar? major trial tests third diabetes pill
Disease control OngoingThis study is testing if adding a medication called pioglitazone helps adults with type 2 diabetes who still have high blood sugar despite taking two common drugs (metformin and empagliflozin). Researchers will compare pioglitazone to a placebo (dummy pill) in about 580 people to…
Phase: PHASE3 • Sponsor: Celltrion • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New copycat drug for psoriasis tested in healthy volunteers
Knowledge-focused OngoingThis early-stage study aims to see if a new, potentially cheaper version of the drug Taltz (called CT-P52) behaves the same way in the body as the original. It involves 218 healthy adults who will receive a single dose of either drug. Researchers will measure drug levels in the b…
Phase: PHASE1 • Sponsor: Celltrion • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC